Roles of different methylation modifications in cardiovascular disease

Abstract

Cardiovascular disease remains the foremost contributor to mortality and disability globally, even with significant advancements in prevention, diagnosis, and early intervention. A comprehensive insight into cardiovascular diseases and the intrinsic molecular mechanisms is critical to innovating more effective therapeutic interventions for prevention and therapy. Latest advancements within the realm of epigenetic modulation, especially methylation modification, of gene expression have corroborated the impacts of epigenetic modifications in governing the pathogenesis and progression of cardiovascular diseases and suggested the viability of epigenetic mechanisms as emerging targets for the development of new diagnostic and therapeutic strategies. In this review, we first provide a brief overview of the biological processes of methylation modifications, including DNA methylation, protein methylation, and RNA N⁶-methyladenosine (m⁶A) modification. We then summarize their roles in cardiac hypertrophy, heart failure, ischemic heart disease, and atherosclerosis.

Keywords

DNA methylation / protein methylation / m⁶A / cardiovascular disease

References

[1] Vaduganathan M , Mensah GA , Turco JV , Fuster V , Roth GA . The global burden of cardiovasculardiseases and risk: a compass for future health. J Am Coll Cardiol 2022; 80(25): 2361–2371

[2] Roth G , Mensah G , Johnson C , Addolorato G , Ammirati E , Baddour L , Barengo N , Beaton A , Benjamin E , Benziger C , Bonny A , Brauer M , Brodmann M , Cahill T , Carapetis J , Catapano A , Chugh S , Cooper L , Coresh J , Criqui M , DeCleene N , Eagle K , Emmons-Bell S , Feigin V , Fernández-Solà J , Fowkes G , Gakidou E , Grundy S , He F , Howard G , Hu F , Inker L , Karthikeyan G , Kassebaum N , Koroshetz W , Lavie C , Lloyd-Jones D , Lu H , Mirijello A , Temesgen A , Mokdad A , Moran A , Muntner P , Narula J , Neal B , Ntsekhe M , Moraes de Oliveira G , Otto C , Owolabi M , Pratt M , Rajagopalan S , Reitsma M , Ribeiro A , Rigotti N , Rodgers A , Sable C , Shakil S , Sliwa-Hahnle K , Stark B , Sundström J , Timpel P , Tleyjeh I , Valgimigli M , Vos T , Whelton P , Yacoub M , Zuhlke L , Murray C , Fuster V; GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group . Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 Study. J Am Coll Cardiol 2020; 76(25): 2982–3021

[3] Wang T , Lu Q , Song H , Hu N , Wei Y , Li P , Liu Y , Zhao Z , Liu J , Zhang B. . DNA Methylation and RNA-sequencing analysis show epigenetic function during grain filling in foxtail millet (Setaria italica L.). Front Plant Sci 2021; 12: 741415

[4] Longo DL , Feinberg AP . The key role of epigenetics in human disease prevention and mitigation. N Engl J Med 2018; 378(14): 1323–1334

[5] Kaji K , Factor V , Andersen J , Durkin M , Tomokuni A , Marquardt J , Matter M , Hoang T , Conner E , Thorgeirsson SJH . DNMT1 is a required genomic regulator for murine liver histogenesis and regeneration. Hepatology 2016; 64(2): 582–598

[6] Berger SL , Kouzarides T , Shiekhattar R , Shilatifard A . An operational definition of epigenetics. Genes Dev 2009; 23(7): 781–783

[7] Fanourgakis G , Gaspa-Toneu L , Komarov P A , Papasaikas P , Ozonov E A , Smallwood S A , Peters A H F M . DNA methylation modulates nucleosome retention in sperm and H3K4 methylation deposition in early mouse embryos. Nat Commun 2025; 16(1): 465

[8] Cedar H , Bergman Y . Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009; 10(5): 295–304

[9] Dykes IM , Emanueli C . Transcriptional and post-transcriptional gene regulation by long non-coding RNA. Genomics Proteomics Bioinformatics 2017; 15(3): 177–186

[10] Chua BA , Van Der Werf I , Jamieson C , Signer R A J . Post-transcriptional regulation of homeostatic, stressed, and malignant stem cells. Cell Stem Cell 2020; 26(2): 138–159

[11] Robertson KD . DNA methylation and human disease. Nat Rev Genet 2005; 6(8): 597–610

[12] Feinberg AP , Tycko B . The history of cancer epigenetics. Nat Rev Cancer 2004; 4(2): 143–153

[13] Smith ZD , Meissner A . DNA methylation: roles in mammalian development. Nat Rev Genet 2013; 14(3): 204–220

[14] Horvath S . DNA methylation age of human tissues and cell types. Genome Biol 2013; 14(10): R115

[15] Li XY , Zhao ZJ , Wang JB , Shao YH , Hui L , You JX , Yang XT . m⁷G methylation-related genes as biomarkers for predicting overall survival outcomes for hepatocellular carcinoma. Front Bioeng Biotechnol 2022; 10: 849756

[16] Jones PA , Baylin SB . The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3(6): 415–428

[17] Dominissini D , Moshitch-Moshkovitz S , Schwartz S , Salmon-Divon M , Ungar L , Osenberg S , Cesarkas K , Jacob-Hirsch J , Amariglio N , Kupiec M , Sorek R , Rechavi G . Topology of the human and mouse m⁶A RNA methylomes revealed by m⁶A-seq. Nature 2012; 485(7397): 201–206

[18] Biggar K , Li SJ . Non-histone protein methylation as a regulator of cellular signalling and function. Nat Rev Mol Cell Biol 2015; 16(1): 5–17

[19] Moore LD , Le T , Fan G . DNA methylation and its basic function. Neuropsychopharmacology 2012; 38(1): 23–38

[20] Portela A , Esteller M . Epigenetic modifications and human disease. Nat Biotechnol 2010; 28(10): 1057–1068

[21] Iacobazzi V , Castegna A , Infantino V , Andria G . Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool. Mol Genet Metab 2013; 110(1-2): 25–34

[22] Jurkowska RZ , Jurkowski TP , Jeltsch A . Structure and function of mammalian DNA methyltransferases. Chembiochem 2011; 12(2): 206–222

[23] Ai X , Zhang YF , Liu JJ , Zhang LR . Analysis of DNA methylation in gene functional regions. J Inner Mongolia Univ (Nat Sci Ed) 2016; 47(3): 290–298

[24] Rakyan V , Whitelaw EJ . Transgenerational epigenetic inheritance. Annu Rev Genet 2003; 13(1): 21–41

[25] Herman JG , Baylin SB . Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349(21): 2042–2054

[26] Ren W , Gao L , Song JJG . Structural basis of DNMT1 and DNMT3A-mediated DNA methylation. Genes (Basel) 2018; 9(12): 620

[27] Estève PO , Zhang G , Ponnaluri VK , Deepti K , Chin HG , Dai N , Sagum C , Black K , Corrêa IR Jr , Bedford MT , Cheng X , Pradhan S . Binding of 14-3-3 reader proteins to phosphorylated DNMT1 facilitates aberrant DNA methylation and gene expression. Nucleic Acids Res 2015; 44(4): 1642–1656

[28] Richard Albert J , Au Yeung W , Toriyama K , Kobayashi H , Hirasawa R , Brind’Amour J , Bogutz A , Sasaki H , Lorincz M . Maternal DNMT3A-dependent de novo methylation of the paternal genome inhibits gene expression in the early embryo. Nat Commun 2020; 11(1): 5417

[29] He Y , Hariharan M , Gorkin D , Dickel D , Luo C , Castanon R , Nery J , Lee A , Zhao Y , Huang H , Williams B , Trout D , Amrhein H , Fang R , Chen H , Li B , Visel A , Pennacchio L , Ren B , Ecker JJN . Spatiotemporal DNA methylome dynamics of the developing mouse fetus. Nature 2020; 583(7818): 752–759

[30] Jones PA , Baylin SB . The epigenomics of cancer. Cell 2007; 128(4): 683–692

[31] Wang F , Qin Z , Li Z , Yang S , Gao T , Sun L , Wang D . Dnmt3aa but not Dnmt3ab is required for maintenance of gametogenesis in nile tilapia (oreochromis niloticus). Int J Mol Sci 2021; 22(18): 10170

[32] Li E , Beard C , Jaenisch R . Role for DNA methylation in genomic imprinting. Nature 1993; 366(6453): 362–365

[33] Ren J , Catalina M D , Eden K , Liao X , Read KA , Luo X , McMillan RP , Hulver MW , Jarpe M , Bachali P , Grammer AC , Lipsky PE , Reilly CM . Selective histone deacetylase 6 inhibition normalizes B cell activation and germinal center formation in a model of systemic lupus erythematosus. Front Immunol 2019; 10: 2512

[34] Ambler RP , Rees MW . Epsilon-N-Methyl-lysine in bacterial flagellar protein. Nature 1959; 184: 56–57

[35] Tang J , Frankel A , Cook RJ , Kim S , Paik WK , Williams KR , Clarke S , Herschman HR . PRMT1 is the predominant type I protein arginine methyltransferase in mammalian cells. J Biol Chem 2000; 275(11): 7723–7730

[36] Boffa LC , Karn J , Vidali G , Allfrey VG . Distribution of NG, NG-dimethylarginine in nuclear protein fractions. Biochem Biophys Res Commun 1977; 74(3): 969–976

[37] Strahl B , Allis CD . The language of covalent histone modifications. Nature 2000; 403(6765): 41–45

[38] Gregory PD , Wagner K , Hörz W . Histone acetylation and chromatin remodeling. Exp Cell Res 2001; 265(2): 195–202

[39] Berger SL . Histone modifications in transcriptional regulation. Curr Opin Genet Dev 2002; 12(2): 142–148

[40] Allfrey VG , Faulkner R , Mirsky AE . Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc Natl Acad Sci USA 1964; 51(5): 786–794

[41] Narita T , Weinert BT , Choudhary C . Functions and mechanisms of non-histone protein acetylation. Nat Rev Mol Cell Biol 2019; 20(3): 156–174

[42] Verdin E , Ott M . 50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond. Nat Rev Mol Cell Biol 2015; 16(4): 258–264

[43] Cantoni G L . Biological methylation: selected aspects. Annu Rev Biochem 1975; 44: 435–451

[44] Greer EL , Shi Y . Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet 2012; 13(5): 343–357

[45] Bannister A J , Kouzarides T . Regulation of chromatin by histone modifications. Cell Res 2011; 21(3): 381–395

[46] Jenuwein T , Allis CD . Translating the histone code. Science 2001; 293(5532): 1074–1080

[47] Bernstein BE , Meissner A , Lander ES . The mammalian epigenome. Cell 2007; 128(4): 669–681

[48] Shi YG , Tsukada Y . The discovery of histone demethylases. Cold Spring Harb Perspect Biol 2013; 5(9): a017947

[49] Carlson SM , Gozani O . Nonhistone lysine methylation in the regulation of cancer pathways. Cold Spring Harb Perspect Med 2016; 6(11): a026435

[50] Xu J , Wang AH , Oses-Prieto J , Makhijani K , Katsuno Y , Pei M , Yan L , Zheng YG , Burlingame A , Brückner K , Derynck R . Arginine methylation initiates BMP-induced smad signaling. Mol Cell 2013; 51(1): 5–19

[51] Chuikov S , Kurash JK , Wilson JR , Xiao B , Justin N , Ivanov GS , McKinney K , Tempst P , Prives C , Gamblin SJ , Barlev NA , Reinberg D . Regulation of p53 activity through lysine methylation. Nature 2004; 432(7015): 353–360

[52] Kwak YT , Guo J , Prajapati S , Park KJ , Surabhi RM , Miller B , Gehrig P , Gaynor RB . Methylation of SPT5 regulates its interaction with RNA polymerase II and transcriptional elongation properties. Mol Cell 2003; 11(4): 1055–1066

[53] Kouskouti A , Scheer E , Staub A , Tora L , Talianidis I . Gene-specific modulation of TAF10 function by SET9-mediated methylation. Mol Cell 2004; 14(2): 175–182

[54] Barbieri I , Kouzarides T . Role of RNA modifications in cancer. Nat Rev Cancer 2020; 20(6): 303–322

[55] Linder B , Grozhik AV , Olarerin-George AO , Meydan C , Mason CE , Jaffrey SR . Single-nucleotide-resolution mapping of m⁶A and m⁶Am throughout the transcriptome. Nat Methods 2015; 12(8): 767–772

[56] Meyer KD , Saletore Y , Zumbo P , Elemento O , Mason CE , Jaffrey SR . Comprehensive analysis of mRNA methylation reveals enrichment in 3′ UTRs and near stop codons. Cell 2012; 149(7): 1635–1646

[57] Li X , Xiong X , Wang K , Wang L , Shu X , Ma S , Yi C . Transcriptome-wide mapping reveals reversible and dynamic N(1)-methyladenosine methylome. Nat Chem Biol 2016; 12(5): 311–316

[58] Squires JE , Patel HR , Nousch M , Sibbritt T , Humphreys DT , Parker BJ , Suter CM , Preiss T . Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA. Nucleic Acids Res 2012; 40(11): 5023–5033

[59] Zou Q , Xing P , Wei L , Liu B . Gene2vec: gene subsequence embedding for prediction of mammalian N(6)-methyladenosine sites from mRNA. RNA 2019; 25(2): 205–218

[60] Desrosiers R , Friderici K , Rottman FJ . Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc Natl Acad Sci USA 1974; 71(10): 3971–3975

[61] Dominissini D , Moshitch-Moshkovitz S , Amariglio N , Rechavi G . Transcriptome-wide mapping of N⁶-methyladenosine by m⁶A-Seq. Methods Enzymol 2015; 560: 131–147

[62] Niu Y , Zhao X , Wu Y , Li M , Wang X , Yang YG . Proteomics, and bioinformatics, N⁶-methyl-adenosine (m⁶A) in RNA: an old modification with a novel epigenetic function. Genomics Proteomics Bioinformatics 2013; 11(1): 8–17

[63] Ke S , Alemu EA , Mertens C , Gantman EC , Fak JJ , Mele A , Haripal B , Zucker-Scharff I , Moore MJ , Park CY , Vågbø CB , Kusśnierczyk A , Klungland A , Darnell JE Jr , Darnell RB . A majority of m⁶A residues are in the last exons, allowing the potential for 3′UTR regulation. Genes Dev 2015; 29(19): 2037–2053

[64] Zhou KI , Shi H , Lyu R , Wylder AC , Matuszek Ż , Pan JN , He C , Parisien M , Pan T . Regulation of Co-transcriptional pre-mRNA Splicing by m⁶A through the low-complexity protein hnRNPG. Mol Cell 2019; 76(1): 70–81.e9

[65] Xiao W , Adhikari S , Dahal U , Chen YS , Hao YJ , Sun BF , Sun HY , Li A , Ping XL , Lai WY , Wang X , Ma HL , Huang CM , Yang Y , Huang N , Jiang GB , Wang HL , Zhou Q , Wang XJ , Zhao YL , Yang YG . Nuclear m⁶A reader YTHDC1 regulates mRNA splicing. Mol Cell 2016; 61(4): 507–519

[66] Schwartz S , Mumbach MR , Jovanovic M , Wang T , Maciag K , Bushkin GG , Mertins P , Ter-Ovanesyan D , Habib N , Cacchiarelli D , Sanjana NE , Freinkman E , Pacold ME , Satija R , Mikkelsen TS , Hacohen N , Zhang F , Carr SA , Lander ES , Regev A . Perturbation of m⁶A writers reveals two distinct classes of mRNA methylation at internal and 5′ sites. Cell Rep 2014; 8(1): 284–296

[67] Zaccara S , Ries RJ , Jaffrey SR . Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol 2019; 20(10): 608–624

[68] Liu J , Yue Y , Han D , Wang X , Fu Y , Zhang L , Jia G , Yu M , Lu Z , Deng X , Dai Q , Chen W , He CJ . N c b, A METTL3-METTL14 complex mediates mammalian nuclear RNA N⁶-adenosine methylation. Nat Chem Biol 2014; 10(2): 93–95

[69] Xu J , Chen Q , Tian K , Liang R , Chen T , Gong A , Mathy NW , Yu T , Chen X . m⁶A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation. Oncol Rep 2020; 44(3): 973–986

[70] Jiang L , Chen T , Xiong L , Xu JH , Gong AY , Dai B , Wu G , Zhu K , Lu E , Mathy N , Chen XM . Knockdown of m⁶A methyltransferase METTL3 in gastric cancer cells results in suppression of cell proliferation. Oncol Lett 2020; 20(3): 2191–2198

[71] Ping XL , Sun BF , Wang L , Xiao W , Yang X , Wang WJ , Adhikari S , Shi Y , Lv Y , Chen YS , Zhao X , Li A , Yang Y , Dahal U , Lou XM , Liu X , Huang J , Yuan WP , Zhu XF , Cheng T , Zhao YL , Wang X , Danielsen JMR , Liu F , Yang YG . Mammalian WTAP is a regulatory subunit of the RNA N⁶-methyladenosine methyltransferase. Cell Res 2014; 24(2): 177–189

[72] Yue Y , Liu J , Cui X , Cao J , Luo G , Zhang Z , Cheng T , Gao M , Shu X , Ma H , Wang F , Wang X , Shen B , Wang Y , Feng X , He C , Liu J . VIRMA mediates preferential m⁶A mRNA methylation in 3′UTR and near stop codon and associates with alternative polyadenylation. Cell Discov 2018; 4: 10

[73] Jia G , Fu Y , Zhao X , Dai Q , Zheng G , Yang Y , Yi C , Lindahl T , Pan T , Yang YG , He C . N⁶-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol 2011; 7(12): 885–887

[74] Zheng G , Dahl JA , Niu Y , Fedorcsak P , Huang CM , Li CJ , Vågbø CB , Shi Y , Wang WL , Song SH , Lu Z , Bosmans RP , Dai Q , Hao YJ , Yang X , Zhao WM , Tong WM , Wang XJ , Bogdan F , Furu K , Fu Y , Jia G , Zhao X , Liu J , Krokan HE , Klungland A , Yang YG , He C . ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell 2013; 49(1): 18–29

[75] Wang X , Zhao B , Roundtree I , Lu Z , Han D , Ma H , Weng X , Chen K , Shi H , He C . N⁶-methyladenosine modulates messenger RNA translation efficiency. Cell 2015; 161(6): 1388–1399

[76] Li M , Zhao X , Wang W , Shi H , Pan Q , Lu Z , Perez S , Suganthan R , He C , Bjørås M , Klungland A . Ythdf2-mediated m⁶A mRNA clearance modulates neural development in mice. Genome Biol 2018; 19(1): 69

[77] Cieniková Z , Damberger F , Hall J , Allain F , Maris CJ . Structural and mechanistic insights into poly(uridine) tract recognition by the hnRNP C RNA recognition motif. J Am Chem Soc 2014; 136(41): 14536–14544

[78] Morice MC . Patients with left main coronary artery disease: stent or surgery. Lancet 2020; 395(10219): 167–168

[79] Handy DE , Castro R , Loscalzo J . Epigenetic modifications: basic mechanisms and role in cardiovascular disease. Circulation 2011; 123(19): 2145–2156

[80] Movassagh M , Choy MK , Knowles DA , Cordeddu L , Haider S , Down T , Siggens L , Vujic A , Simeoni I , Penkett C , Goddard M , Lio P , Bennett MR , Foo RS . Distinct epigenomic features in end-stage failing human hearts. Circulation 2011; 124(22): 2411–2422

[81] Thienpont B , Aronsen JM , Robinson EL , Okkenhaug H , Loche E , Ferrini A , Brien P , Alkass K , Tomasso A , Agrawal A , Bergmann O , Sjaastad I , Reik W , Roderick HL . The H3K9 dimethyltransferases EHMT1/2 protect against pathological cardiac hypertrophy. J Clin Invest 2017; 127(1): 335–348

[82] Zheng Y , Li Y , Ran X , Wang D , Zheng X , Zhang M , Yu B , Sun Y , Wu J . Mettl14 mediates the inflammatory response of macrophages in atherosclerosis through the NF-κB/IL-6 signaling pathway. Cell Mol Life Sci 2022; 79(6): 311

[83] Yan Y , He YY , Jiang X , Wang Y , Chen JW , Zhao JH , Ye J , Lian TY , Zhang X , Zhang RJ , Lu D , Guo SS , Xu XQ , Sun K , Li SQ , Zhang LF , Zhang X , Zhang SY , Jing ZC . DNA methyltransferase 3B deficiency unveils a new pathological mechanism of pulmonary hypertension. Sci Adv 2020; 6(50): eaba2470

[84] Lee M , Chen MJ . Diagnosis and management of congenital coronary arteriovenous fistula in the pediatric patients presenting congestive heart failure and myocardial ischemia. Yonsei Med J 2009; 50(1): 95–104

[85] Nowbar AN , Gitto M , Howard JP , Francis DP , Al-Lamee R . Mortality from ischemic heart disease. Circ Cardiovasc Qual Outcomes 2019; 12(6): e005375

[86] Heusch G , Gersh BJ . The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J 2017; 38(11): 774–784

[87] Shi Y , Zhang H , Huang S , Yin L , Wang F , Luo P , Huang H . Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials. Signal Transduct Target Ther 2022; 7(1): 200

[88] Greco CM , Kunderfranco P , Rubino M , Larcher V , Carullo P , Anselmo A , Kurz K , Carell T , Angius A , Latronico MV , Papait R , Condorelli G . DNA hydroxymethylation controls cardiomyocyte gene expression in development and hypertrophy. Nat Commun 2016; 7: 12418

[89] Chen Z , Gong L , Zhang P , Li Y , Liu B , Zhang L , Zhuang J , Xiao D . Epigenetic down-regulation of Sirt 1 via DNA methylation and oxidative stress signaling contributes to the gestational diabetes mellitus-induced fetal programming of heart ischemia-sensitive phenotype in late life. Int J Biol Sci 2019; 15(6): 1240–1251

[90] Jian J , Zhang P , Li Y , Liu B , Zhang Y , Zhang L , Shao X , Zhuang J , Xiao DJT . Reprogramming of miR-181a/DNA methylation patterns contribute to the maternal nicotine exposure-induced fetal programming of cardiac ischemia-sensitive phenotype in postnatal life. Theranostics 2020; 10(25): 11820–11836

[91] Li J , Zhu X , Yu K , Jiang H , Zhang Y , Deng S , Cheng L , Liu X , Zhong J , Zhang X , He M , Chen W , Yuan J , Gao M , Bai Y , Han X , Liu B , Luo X , Mei W , He X , Sun S , Zhang L , Zeng H , Sun H , Liu C , Guo Y , Zhang B , Zhang Z , Huang J , Pan A , Yuan Y , Angileri F , Ming B , Zheng F , Zeng Q , Mao X , Peng Y , Mao Y , He P , Wang Q , Qi L , Hu F , Liang L , Wu TJ . Genome-wide analysis of DNA methylation and acute coronary syndrome. Circ Res 2017; 120(11): 1754–1767

[92] Ma S , Zhang H , Kong F , Zhang H , Yang C , He Y , Wang Y , Yang A , Tian J , Yang X , Zhang M , Xu H , Jiang Y , Yu ZJ . Integration of gene expression and DNA methylation profiles provides a molecular subtype for risk assessment in atherosclerosis. Mol Med Rep 2016; 13(6): 4791–4799

[93] Corbin LJ , White SJ , Taylor AE , Williams CM , Taylor K , van den Bosch MT , Teasdale JE , Jones M , Bond M , Harper MT , Falk L , Groom A , Hazell GGJ , Paternoster L , Munafò MR , Nordestgaard BG , Tybjærg-Hansen A , Bojesen SE , Relton C , Min JL , Davey Smith G , Mumford AD , Poole AW , Timpson NJ . Epigenetic regulation of F2RL3 associates with myocardial infarction and platelet function. Circ Res 2022; 130(3): 384–400

[94] Li M , Jiao L , Shao Y , Li H , Sun L , Yu Q , Gong M , Liu D , Wang Y , Xuan L , Yang X , Qu Y , Wang Y , Jiang L , Han J , Zhang Y , Zhang Y . LncRNA-ZFAS1 promotes myocardial ischemia-reperfusion injury through DNA methylation-mediated Notch1 down-regulation in mice. JACC Basic Transl Sci 2022; 7(9): 880–895

[95] Bedford MT , Clarke SG . Protein arginine methylation in mammals: who, what, and why. Mol Cell 2009; 33(1): 1–13

[96] Morales Y , Cáceres T , May K , Hevel JM . Biochemistry and regulation of the protein arginine methyltransferases (PRMTs). Arch Biochem Biophys 2016; 590: 138–152

[97] Yang Y , Bedford MT . Protein arginine methyltransferases and cancer. Nat Rev Cancer 2013; 13(1): 37–50

[98] Kim JH , Yoo BC , Yang WS , Kim E , Hong S , Cho JY . The role of protein arginine methyltransferases in inflammatory responses. Mediators Inflamm 2016; 2016: 4028353

[99] Silva ACE , Wu YC , Citadin CT , Clemons GA , Lin HW . Protein arginine methyltransferases in cardiovascular and neuronal function. Mol Neurobiol 2020; 57(3): 1716–1732

[100] Angelopoulou E , Pyrgelis ES , Ahire C , Suman P , Mishra A , Piperi C . Functional implications of protein arginine methyltransferases (PRMTs) in neurodegenerative diseases. Biology (Basel) 2023; 12(9): 1257

[101] Zhou S , Zhang Q , Yang H , Zhu Y , Hu X , Wan G , Yu L . Targeting type I PRMTs as promising targets for the treatment of pulmonary disorders: Asthma, COPD, lung cancer, PF, and PH. Life Sci 2024; 342: 122538

[102] Jarrold J , Davies CC . PRMTs and arginine methylation: cancer’s best-kept secret. Trends Mol Med 2019; 25(11): 993–1009

[103] Wang Y , Ju C , Hu J , Huang K , Yang L . PRMT4 overexpression aggravates cardiac remodeling following myocardial infarction by promoting cardiomyocyte apoptosis. Biochem Biophys Res Commun 2019; 520(3): 645–650

[104] Tan B , Liu Q , Yang L , Yang Y , Liu D , Liu L , Meng F . Low expression of PRMT5 in peripheral blood may serve as a potential independent risk factor in assessments of the risk of stable CAD and AMI. BMC Cardiovasc Disord 2019; 19(1): 31

[105] Snitow M , Lu MM , Cheng L , Zhou S , Morrisey EE . Ezh2 restricts the smooth muscle lineage during mouse lung mesothelial development. Development 2016; 143(20): 3733–3741

[106] Wan J , Hou X , Zhou Z , Geng J , Tian J , Bai X , Nie J . WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy. Free Radic Biol Med 2017; 108: 280–299

[107] Wang C , Liu G , Yang H , Guo S , Wang H , Dong Z , Li X , Bai Y , Cheng Y . MALAT1-mediated recruitment of the histone methyltransferase EZH2 to the microRNA-22 promoter leads to cardiomyocyte apoptosis in diabetic cardiomyopathy. Sci Total Environ 2021; 766: 142191

[108] Yang J , Shangguan Q , Xie G , Yang M , Sheng G . M⁶A regulator methylation patterns and characteristics of immunity in acute ST-segment elevation myocardial infarction. Sci Rep 2023; 13(1): 15688

[109] Liu L , Wu J , Lu C , Ma Y , Wang J , Xu J , Yang X , Zhang X , Wang H , Xu J , Zhang J . WTAP-mediated m⁶A modification of lncRNA Snhg1 improves myocardial ischemia-reperfusion injury via miR-361–5p/OPA1-dependent mitochondrial fusion. J Transl Med 2024; 22(1): 499

[110] Koshinuma S , Miyamae M , Kaneda K , Kotani J , Figueredo VM . Combination of necroptosis and apoptosis inhibition enhances cardioprotection against myocardial ischemia-reperfusion injury. J Anesth 2014; 28(2): 235–241

[111] Gu S , Tan J , Li Q , Liu S , Ma J , Zheng Y , Liu J , Bi W , Sha P , Li X , Wei M , Cao N , Yang HT . Downregulation of LAPTM4B contributes to the impairment of the autophagic flux via unopposed activation of mTORC1 signaling during myocardial ischemia/reperfusion injury. Circ Res 2020; 127(7): e148–e165

[112] Sun Y , Ma M , Cao D , Zheng A , Zhang Y , Su Y , Wang J , Xu Y , Zhou M , Tang Y , Liu Y , Ma T , Fan A , Zhang X , Zhu Q , Qin J , Mo C , Xu Y , Zhang L , Xu D , Yue R . Inhibition of fap promotes cardiac repair by stabilizing BNP. Circ Res 2023; 132(5): 586–600

[113] Song H , Feng X , Zhang H , Luo Y , Huang J , Lin M , Jin J , Ding X , Wu S , Huang H , Yu T , Zhang M , Hong H , Yao S , Zhao Y , Zhang ZJA . TFEBMETTL3 and ALKBH5 oppositely regulate m⁶A modification of mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes. Autophagy 2019; 15(8): 1419–1437

[114] Yang K , Zhao Y , Hu J , Gao R , Shi J , Wei X , Chen J , Hu K , Sun A , Ge J . ALKBH5 induces fibroblast-to-myofibroblast transformation during hypoxia to protect against cardiac rupture after myocardial infarction. J Adv Res 2024; 61: 193–209

[115] Zhao Y , Hu J , Sun X , Yang K , Yang L , Kong L , Zhang B , Li F , Li C , Shi B , Hu K , Sun A , Ge J . Loss of m⁶A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A. Clin Transl Med 2021; 11(5): e402

[116] Nakamura M , Sadoshima J . Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol 2018; 15(7): 387–407

[117] Guo H , Ma K , Hao W , Jiao Y , Li P , Chen J , Xu C , Xu FJ , Lau WB , Du J , Ma XL , Li Y . mir15a/mir16–1 cluster and its novel targeting molecules negatively regulate cardiac hypertrophy. Clin Transl Med 2020; 10(8): e242

[118] Dong Y , Xu S , Liu J , Ponnusamy M , Zhao Y , Zhang Y , Wang Q , Li P , Wang K . Non-coding RNA-linked epigenetic regulation in cardiac hypertrophy. Int J Biol Sci 2018; 14(9): 1133–1141

[119] Stenzig J , Hirt M , Löser A , Bartholdt L , Hensel J , Werner T , Riemenschneider M , Indenbirken D , Guenther T , Müller C , Hübner N , Stoll M , Eschenhagen TJ . DNA methylation in an engineered heart tissue model of cardiac hypertrophy: common signatures and effects of DNA methylation inhibitors. Basic Res Cardiol 2016; 111(1): 9

[120] Xiao D , Dasgupta C , Chen M , Zhang K , Buchholz J , Xu Z , Zhang LJ . Inhibition of DNA methylation reverses norepinephrine-induced cardiac hypertrophy in rats. Cardiovasc Res 2014; 101(3): 373–382

[121] Huang L , Xi Z , Wang C , Zhang Y , Yang Z , Zhang S , Chen Y , Zuo Z . Phenanthrene exposure induces cardiac hypertrophy via reducing miR-133a expression by DNA methylation. Sci Rep 2016; 6: 20105

[122] Black JC , Van Rechem C , Whetstine JR . Histone lysine methylation dynamics: establishment, regulation, and biological impact. Mol Cell 2012; 48(4): 491–507

[123] Jones PA , Issa JPJ , Baylin S . Targeting the cancer epigenome for therapy. Nat Rev Genet 2016; 17(10): 630–641

[124] Piunti A , Shilatifard A . Epigenetic balance of gene expression by Polycomb and COMPASS families. Science 2016; 352(6290): aad9780

[125] Gillette TG , Hill JA . Readers, writers, and erasers: chromatin as the whiteboard of heart disease. Circ Res 2015; 116(7): 1245–1253

[126] Greco CM , Condorelli G . Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure. Nat Rev Cardiol 2015; 12(8): 488–497

[127] El-Nachef D , Oyama K , Wu YY , Freeman M , Zhang Y , MacLellan WR . Repressive histone methylation regulates cardiac myocyte cell cycle exit. J Mol Cell Cardiol 2018; 121: 1–12

[128] Shinkai Y , Tachibana M . H3K9 methyltransferase G9a and the related molecule GLP. Genes Dev 2011; 25(8): 781–788

[129] Papait R , Serio S , Pagiatakis C , Rusconi F , Carullo P , Mazzola M , Salvarani N , Miragoli M , Condorelli G . Histone methyltransferase G9a is required for cardiomyocyte homeostasis and hypertrophy. Circulation 2017; 136(13): 1233–1246

[130] Zhou XL , Zhu RR , Wu X , Xu H , Li YY , Xu QR , Liu S , Huang H , Xu X , Wan L , Wu QC , Liu JC . NSD2 promotes ventricular remodelling mediated by the regulation of H3K36me2. J Cell Mol Med 2019; 23(1): 568–575

[131] Chen M , Yi B , Sun J . Inhibition of cardiomyocyte hypertrophy by protein arginine methyltransferase 5. J Biol Chem 2014; 289(35): 24325–24335

[132] Cai S , Wang P , Xie T , Li Z , Li J , Lan R , Ding Y , Lu J , Ye J , Wang J , Li Z , Liu P . Histone H4R3 symmetric di-methylation by Prmt5 protects against cardiac hypertrophy via regulation of Filip1L/β-catenin. Pharmacol Res 2020; 161: 105104

[133] Wang Z , Zhang XJ , Ji YX , Zhang P , Deng KQ , Gong J , Ren S , Wang X , Chen I , Wang H , Gao C , Yokota T , Ang YS , Li S , Cass A , Vondriska TM , Li G , Deb A , Srivastava D , Yang HT , Xiao X , Li H , Wang Y . The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy. Nat Med 2016; 22(10): 1131–1139

[134] Dorn L , Lasman L , Chen J , Xu X , Hund T , Medvedovic M , Hanna J , van Berlo J , Accornero FJC . The N-methyladenosine mRNA methylase METTL3 controls cardiac homeostasis and hypertrophy. Circulation 2019; 139(4): 533–545

[135] Xu H , Wang Z , Chen M , Zhao W , Tao T , Ma L , Ni Y , Li W . YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decoy. Cell Biosci 2021; 11(1): 132

[136] Golubeva VA , Dorn L , Gilbert CJ , Rabolli CP , Das AS , Wanasinghe V , Veress R , Terentyev D , Accornero F . Loss of YTHDF2 alters the expression of m⁶A-modified myzap and causes adverse cardiac remodeling. JACC Basic Transl Sci 2023; 8(9): 1180–1194

[137] Meng C , Su H , Shu M , Shen F , Lu Y , Wu S , Su Z , Yu M , Yang D . The functional role of m⁶A demethylase ALKBH5 in cardiomyocyte hypertrophy. Cell Death Dis 2024; 15(9): 683

[138] Yancy CW , Jessup M , Bozkurt B , Butler J , Casey DE Jr , Drazner MH , Fonarow GC , Geraci SA , Horwich T , Januzzi JL , Johnson MR , Kasper EK , Levy WC , Masoudi FA , McBride PE , McMurray JJ , Mitchell JE , Peterson PN , Riegel B , Sam F , Stevenson LW , Tang WH , Tsai EJ , Wilkoff BL . 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013; 128(16): 1810–1852

[139] Tu D , Ma C , Zeng Z , Xu Q , Guo Z , Song X , Zhao X . Identification of hub genes and transcription factor regulatory network for heart failure using RNA-seq data and robust rank aggregation analysis. Front Cardiovasc Med 2022; 9: 916429

[140] Goodman JB , Qin F , Morgan RJ , Chambers JM , Croteau D , Siwik DA , Hobai I , Panagia M , Luptak I , Bachschmid M , Tong XY , Pimentel DR , Cohen RA , Colucci WS . Redox-resistant SERCA [sarco(endo)plasmic reticulum calcium ATPase] attenuates oxidant-stimulated mitochondrial calcium and apoptosis in cardiac myocytes and pressure overload—induced myocardial failure in mice. Circulation 2020; 142(25): 2459–2469

[141] Huang H , Weng H , Sun W , Qin X , Shi H , Wu H , Zhao BS , Mesquita A , Liu C , Yuan CL , Hu YC , Hüttelmaier S , Skibbe JR , Su R , Deng X , Dong L , Sun M , Li C , Nachtergaele S , Wang Y , Hu C , Ferchen K , Greis KD , Jiang X , Wei M , Qu L , Guan JL , He C , Yang J , Chen J . Recognition of RNA N⁶-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol 2018; 20(3): 285–295

[142] Zhang Y , Jiao L , Sun L H , Li Y , Yang B . LncRNA ZFAS1 as a SERCA2a inhibitor to cause intracellular Ca²⁺ overload and contractile dysfunction in a mouse model of myocardial infarction. Circ Res 2018; 122(10): 1354–1368

[143] Traister A , Li M A S , Lu M A S , Radisic M , Gross G , Guido F , Sherret J , Verma S , Slorach C , Mertens L , Hui W , Roy A , Delgado-Olguín P , Hannigan G , Maynes JT , Coles JG . Integrin-linked kinase mediates force transduction in cardiomyocytes by modulating SERCA2a/PLN function. Nat Commun 2014; 5: 4533

[144] Leopoldo AS , Lima-Leopoldo AP , Sugizaki MM , Nascimento A , de Campos DHS , Luvizotto RAM , Castardeli E , Alves CAB , Brum PC , Cicogna AC . Involvement of L-type calcium channel and SERCA2a in myocardial dysfunction induced by obesity. J Cell Physiol 2011; 226(11): 2934–2942

[145] Zhai Y , Luo Y , Wu P , Li D . New insights into SERCA2a gene therapy in heart failure: pay attention to the negative effects of B-type natriuretic peptides. J Med Genet 2018; 55(5): 287–296

[146] Zhihao L , Jingyu N , Lan L , Michael S , Rui G , Xiyun B , Xiaozhi L , Guanwei F . SERCA2a: a key protein in the Ca2+ cycle of the heart failure. Heart Fail Rev 2020; 25(3): 523–535

[147] Gorski PA , Jang SP , Jeong D , Lee A , Lee P , Oh JG , Chepurko V , Yang DK , Kwak TH , Eom SH , Park ZY , Yoo YJ , Kim DH , Kook H , Sunagawa Y , Morimoto T , Hasegawa K , Sadoshima J , Vangheluwe P , Hajjar RJ , Park WJ , Kho C . Role of SIRT1 in modulating acetylation of the sarco-endoplasmic reticulum Ca²⁺-ATPase in heart failure. Circ Res 2019; 124(9): e63–e80

[148] Movassagh M , Choy M , Goddard M , Bennett M , Down T , Foo RJ . Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure. PLoS One 2010; 5(1): e8564

[149] Ritchie RH , Abel ED . Basic mechanisms of diabetic heart disease. Circ Res 2020; 126(11): 1501–1525

[150] Haas J , Frese K , Park Y , Keller A , Vogel B , Lindroth A , Weichenhan D , Franke J , Fischer S , Bauer A , Marquart S , Sedaghat-Hamedani F , Kayvanpour E , Köhler D , Wolf N , Hassel S , Nietsch R , Wieland T , Ehlermann P , Schultz J , Dösch A , Mereles D , Hardt S , Backs J , Hoheisel J , Plass C , Katus H , Meder BJ . Alterations in cardiac DNA methylation in human dilated cardiomyopathy. EMBO Mol Med 2013; 5(3): 413–429

[151] Kao Y , Chen Y , Cheng C , Lee T , Chen Y , Chen SJ . Tumor necrosis factor-alpha decreases sarcoplasmic reticulum Ca²⁺-ATPase expressions via the promoter methylation in cardiomyocytes. Crit Care Med 2010; 38(1): 217–222

[152] Dabrowski MJ , Wojtas B . Global DNA methylation patterns in human gliomas and their interplay with other epigenetic modifications. Int J Mol Sci 2019; 20(14): 3478

[153] He A , Kong SW , Ma Q , Pu WT . Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart. Proc Natl Acad Sci USA 2011; 108(14): 5632–5637

[154] Wamstad JA , Alexander JM , Truty RM , Shrikumar A , Li F , Eilertson KE , Ding H , Wylie JN , Pico AR , Capra JA , Erwin G , Kattman SJ , Keller GM , Srivastava D , Levine SS , Pollard KS , Holloway AK , Boyer LA , Bruneau BG . Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage. Cell 2012; 151(1): 206–220

[155] Kaneda R , Takada S , Yamashita Y , Choi Y L , Nonaka-Sarukawa M , Soda M , Misawa Y , Isomura T , Shimada K , Mano H . Genome-wide histone methylation profile for heart failure. Genes Cells 2009; 14(1): 69–77

[156] Stein AB , Jones TA , Herron TJ , Patel SR , Day SM , Noujaim SF , Milstein ML , Klos M , Furspan PB , Jalife J , Dressler GR . Loss of H3K4 methylation destabilizes gene expression patterns and physiological functions in adult murine cardiomyocytes. J Clin Invest 2011; 121(7): 2641–2650

[157] Beltran-Alvarez P , Tarradas A , Chiva C , Pérez-Serra A , Batlle M , Pérez-Villa F , Schulte U , Sabidó E , Brugada R , Pagans S . Identification of N-terminal protein acetylation and arginine methylation of the voltage-gated sodium channel in end-stage heart failure human heart. J Mol Cell Cardiol 2014; 76: 126–129

[158] Saito Y , Nakao K , Arai H , Nishimura K , Okumura K , Obata K , Takemura G , Fujiwara H , Sugawara A , Yamada T . Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart. J Clin Invest 1989; 83(1): 298–305

[159] Hohl M , Wagner M , Reil JC , Müller SA , Tauchnitz M , Zimmer AM , Lehmann LH , Thiel G , Böhm M , Backs J , Maack C . HDAC4 controls histone methylation in response to elevated cardiac load. J Clin Invest 2013; 123(3): 1359–1370

[160] Mathiyalagan P , Adamiak M , Mayourian J , Sassi Y , Liang Y , Agarwal N , Jha D , Zhang S , Kohlbrenner E , Chepurko E , Chen J , Trivieri M , Singh R , Bouchareb R , Fish K , Ishikawa K , Lebeche D , Hajjar R , Sahoo SJC . FTO-dependent N-methyladenosine regulates cardiac function during remodeling and repair. Circulation 2019; 139(4): 518–532

[161] Shi L , Li X , Zhang M , Qin C , Zhang Z , Chen Z . Downregulation of Wtap causes dilated cardiomyopathy and heart failure. J Mol Cell Cardiol 2024; 188: 38–51

[162] Schiano C , Benincasa G , Franzese M , Della Mura N , Pane K , Salvatore M , Napoli C . Epigenetic-sensitive pathways in personalized therapy of major cardiovascular diseases. Pharmacol Ther 2020; 210: 107514

[163] Alexander MR , Owens GK . Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol 2012; 74: 13–40

[164] Schleithoff C , Voelter-Mahlknecht S , Dahmke IN , Mahlknecht U . On the epigenetics of vascular regulation and disease. Clin Epigenetics 2012; 4(1): 7

[165] Xu S , Kamato D , Little PJ , Nakagawa S , Pelisek J , Jin ZG . Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics. Pharmacol Ther 2019; 196: 15–43

[166] Neele AE , Willemsen L , Chen HJ , Dzobo KE , de Winther MPJ . Targeting epigenetics as atherosclerosis treatment: an updated view. Curr Opin Lipidol 2020; 31(6): 324–330

[167] Newman PE . Can reduced folic acid and vitamin B₁₂ levels cause deficient DNA methylation producing mutations which initiate atherosclerosis. Med Hypotheses 1999; 53(5): 421–424

[168] Hiltunen MO , Turunen MP , Häkkinen TP , Rutanen J , Hedman M , Mäkinen K , Turunen AM , Aalto-Setalä K , Ylä-Herttuala S . DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vasc Med 2002; 7(1): 5–11

[169] Kim M , Long T , Arakawa K , Wang R , Yu M , Laird PJ . DNA methylation as a biomarker for cardiovascular disease risk. PLoS One 2010; 5(3): e9692

[170] Huang Y , Zhi Y , Wang SJ . Hypermethylation of estrogen receptor-alpha gene in atheromatosis patients and its correlation with homocysteine. Pathophysiology 2009; 16(4): 259–265

[171] Laukkanen M , Mannermaa S , Hiltunen M , Aittomäki S , Airenne K , Jänne J , Ylä-Herttuala S . Local hypomethylation in atherosclerosis found in rabbit ec-sod gene. Arterioscler Thromb Vasc Biol 1999; 19(9): 2171–2178

[172] Zhu S , Goldschmidt-Clermont P , Dong C . Inactivation of monocarboxylate transporter MCT3 by DNA methylation in atherosclerosis. Circulation 2005; 112(9): 1353–1361

[173] Liu C , Xu D , Sjöberg J , Forsell P , Björkholm M , Claesson HJ . Transcriptional regulation of 15-lipoxygenase expression by promoter methylation. PLoS One 2004; 297(1): 61–67

[174] Zakrzewicz D , Eickelberg O . From arginine methylation to ADMA: a novel mechanism with therapeutic potential in chronic lung diseases. BMC pulmonary medicine 2009; 9: 5

[175] Stühlinger MC , Tsao PS , Her JH , Kimoto M , Balint RF , Cooke JP . Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation 2001; 104(21): 2569–2575

[176] Kielstein JT , Bode-Böger SM , Hesse G , Martens-Lobenhoffer J , Takacs A , Fliser D , Hoeper MM . Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension. Arterioscler Thromb Vasc Biol 2005; 25(7): 1414–1418

[177] Vallance P , Leiper J . Blocking NO synthesis: how, where and why. Nat Rev Drug Discov 2002; 1(12): 939–950

[178] Di Pietro N , Formoso G , Pandolfi A . Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis. Vascular pharmacology 2016; 84: 1–7

[179] Chan JR , Böger RH , Bode-Böger SM , Tangphao O , Tsao PS , Blaschke TF , Cooke JP . Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans. Arterioscler Thromb Vasc Biol 2000; 20(4): 1040–1046

[180] Eid HM , Eritsland J , Larsen J , Arnesen H , Seljeflot I . Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin. Atherosclerosis 2003; 166(2): 279–284

[181] Elesber AA , Solomon H , Lennon RJ , Mathew V , Prasad A , Pumper G , Nelson RE , McConnell JP , Lerman LO , Lerman A . Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis. Eur Heart J 2006; 27(7): 824–831

[182] Furuki K , Adachi H , Matsuoka H , Enomoto M , Satoh A , Hino A , Hirai Y , Imaizumi T . Plasma levels of asymmetric dimethylarginine (ADMA) are related to intima-media thickness of the carotid artery: an epidemiological study. Atherosclerosis 2007; 191(1): 206–210

[183] Miyazaki H , Matsuoka H , Cooke JP , Usui M , Ueda S , Okuda S , Imaizumi T . Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation 1999; 99(9): 1141–1146

[184] Wierda RJ , Rietveld IM , van Eggermond MC , Belien JA , van Zwet EW , Lindeman JH , van den Elsen PJ . Global histone H3 lysine 27 triple methylation levels are reduced in vessels with advanced atherosclerotic plaques. Life Sci 2015; 129: 3–9

[185] Lv YC , Tang YY , Zhang P , Wan W , Yao F , He PP , Xie W , Mo ZC , Shi JF , Wu JF , Peng J , Liu D , Cayabyab FS , Zheng XL , Tang XY , Ouyang XP , Tang CK . Histone methyltransferase enhancer of zeste homolog 2-mediated ABCA1 promoter DNA methylation contributes to the progression of atherosclerosis. PLoS One 2016; 11(6): e0157265

[186] Meng XD , Yao HH , Wang LM , Yu M , Shi S , Yuan ZX , Liu J . Knockdown of GAS5 inhibits atherosclerosis progression via reducing EZH2-mediated ABCA1 transcription in ApoE^−/− mice. Mol Ther Nucleic Acids 2020; 19: 84–96

[187] Wu L , Pei Y , Zhu Y , Jiang M , Wang C , Cui W , Zhang DJ . Association of N-methyladenine DNA with plaque progression in atherosclerosis via myocardial infarction-associated transcripts. Cell Death Dis 2019; 10(12): 909

[188] Jian D , Wang Y , Jian L , Tang H , Rao L , Chen K , Jia Z , Zhang W , Liu Y , Chen X , Shen X , Gao C , Wang S , Li M . METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications. Theranostics 2020; 10(20): 8939–8956

[189] Zhang B , Han L , Tang Y , Zhang G , Fan X , Zhang J , Xue Q , Xu ZJ . METTL14 regulates M⁶A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion. Eur Rev Med Pharmacol Sci 2020; 24(12): 7015–7023

[190] Gong C , Fan Y , Liu JJ . METTL14 mediated m⁶A modification to lncRNA ZFAS1/RAB22A: a novel therapeutic target for atherosclerosis. Int J Cardiol 2020; 328: 177

[191] Li Q , Yu L , Gao A , Ren R , Zhang J , Cao L , Wang X , Liu Y P , Qi W , Cai L . METTL3 (methyltransferase like 3)-dependent N⁶-methyladenosine modification on Braf mRNA promotes macrophage inflammatory response and atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2023; 43(5): 755–773

[192] Sun Z , Chen W , Wang Z , Wang S , Zan J , Zheng L , Zhao W . Matr3 reshapes m⁶A modification complex to alleviate macrophage inflammation during atherosclerosis. Clin Immunol 2022; 245: 109176

[193] Yu X , Zhang Y , Wang J , Wang X , Chen X , Yin K , Zhu X . Leonurine improves atherosclerosis by activating foam cell autophagy and metabolic remodeling via METTL3-mediated AKT1S1 mRNA stability modulation. Phytomedicine 2024; 134: 155939

[194] Wang X , Elling AA , Li X , Li N , Peng Z , He G , Sun H , Qi Y , Liu XS , Deng XW . Genome-wide and organ-specific landscapes of epigenetic modifications and their relationships to mRNA and small RNA transcriptomes in maize. Plant Cell 2009; 21(4): 1053–1069

[195] Osakabe A , Adachi F , Arimura Y , Maehara K , Ohkawa Y , Kurumizaka H . Influence of DNA methylation on positioning and DNA flexibility of nucleosomes with pericentric satellite DNA. Open Biol 2015; 5(10): 150128

[196] Morselli M , Pastor W A , Montanini B , Nee K , Ferrari R , Fu K , Bonora G , Rubbi L , Clark AT , Ottonello S . In vivo targeting of de novo DNA methylation by histone modifications in yeast and mouse. Elife 2015; 4: e06205

[197] Du J , Johnson LM , Jacobsen SE , Patel DJ . DNA methylation pathways and their crosstalk with histone methylation. Nat Rev Mol Cell Biol 2015; 16(9): 519–532

[198] Li G , Luo R , Zhang WF , He S , Wang B , Liang H , Song Y , Ke W , Shi Y , Feng X , Zhao K , Wu X , Zhang Y , Wang K , Yang C . m⁶A hypomethylation of DNMT3B regulated by ALKBH5 promotes intervertebral disc degeneration via E4F1 deficiency. Clin Transl Med 2022; 12(3): e765

[199] Majid S , Dar AA , Saini S , Shahryari V , Arora S , Zaman MS , Chang I , Yamamura S , Tanaka Y , Chiyomaru T , Deng G , Dahiya R . miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways. Clin Cancer Res 2013; 19(1): 73–84

[200] Yu F , Lu Z , Chen B , Wu X , Dong P , Zheng J . Salvianolic acid B-induced microRNA-152 inhibits liver fibrosis by attenuating DNMT1-mediated Patched1 methylation. J Cell Mol Med 2015; 19(11): 2617–2632

[201] Yu Y , Qi J , Xiong J , Jiang L , Cui D , He J , Chen P , Li L , Wu C , Ma T , Shao S , Wang J , Yu D , Zhou B , Huang D , Schmitt CA , Tao R . Epigenetic co-deregulation of EZH2/TET1 is a senescence-countering, actionable vulnerability in triple-negative breast cancer. Theranostics 2019; 9(3): 761–777

[202] Houghton SC , Eliassen AH , Zhang SM , Selhub J , Rosner BA , Willett WC , Hankinson SE . Plasma B-vitamin and one-carbon metabolites and risk of breast cancer before and after folic acid fortification in the United States. Int J Cancer 2019; 144(8): 1929–1940

[203] Yuan H , Reddy M , Deshpande S , Jia Y , Park JT , Lanting L , Jin W , Kato M , Xu ZG , Das S . Epigenetic histone modifications involved in profibrotic gene regulation by 12/15-lipoxygenase and its oxidized lipid products in diabetic nephropathy. Antioxid Redox Signal 2016; 24(7): 361–375

[204] Lund AH , van Lohuizen M . Polycomb complexes and silencing mechanisms. Curr Opin Cell Biol 2004; 16(3): 239–246

[205] Petell C J , Alabdi L , He M , San Miguel P , Rose R , Gowher H . An epigenetic switch regulates DNA methylation at a subset of pluripotency gene enhancers during embryonic stem cell differentiation. Nucleic Acids Res 2016; 44(16): 7605–7617

[206] Chomiak AA , Tiedemann RL , Liu Y , Kong X , Cui Y , Wiseman AK , Thurlow KE , Cornett EM , Topper MJ , Baylin SB , Rothbart SB . Select EZH2 inhibitors enhance viral mimicry effects of DNMT inhibition through a mechanism involving NFAT: AP-1 signaling. Sci Adv 2024; 10(13): eadk4423

[207] Jackson M , Krassowska A , Gilbert N , Chevassut T , Forrester L , Ansell J , Ramsahoye B . Severe global DNA hypomethylation blocks differentiation and induces histone hyperacetylation in embryonic stem cells. Mol Cell Biol 2004; 24(20): 8862–8871

[208] Xu H , Zhou Q , Yi Q , Tan B , Tian J , Chen X , Wang Y , Yu X , Zhu J . Islet-1 synergizes with Gcn5 to promote MSC differentiation into cardiomyocytes. Sci Rep 2020; 10(1): 1817

[209] Matzke MA , Mosher RA . RNA-directed DNA methylation: an epigenetic pathway of increasing complexity. Nat Rev Genet 2014; 15(6): 394–408

[210] Panopoulos AD , Smith EN , Arias AD , Shepard PJ , Hishida Y , Modesto V , Diffenderfer KE , Conner C , Biggs W , Sandoval E , D'Antonio-Chronowska A , Berggren WT , Izpisua Belmonte JC , Frazer KA . Aberrant DNA methylation in human iPSCs associates with MYC-binding motifs in a clone-specific manner independent of genetics. Cell Stem Cell 2017; 20(4): 505–517.e6

[211] Melnik BC . Milk: an epigenetic amplifier of FTO-mediated transcription? Implications for Western diseases. J Transl Med 2015; 13: 385

[212] Yao Q , Chen Y , Zhou X . The roles of microRNAs in epigenetic regulation. Curr Opin Chem Biol 2019; 51: 11–17

[213] Villela D , Ramalho RF , Silva AR , Brentani H , Suemoto CK , Pasqualucci CA , Grinberg LT , Krepischi AC , Rosenberg C . Differential DNA methylation of microRNA genes in temporal cortex from Alzheimer’s disease individuals. Neural Plast 2016; 2016: 2584940

[214] Zhang P , Sun H , Yang B , Luo W , Liu Z , Wang J , Zuo Y . miR-152 regulated glioma cell proliferation and apoptosis via Runx2 mediated by DNMT1. Biomedicine & Pharmacotherapy 2017; 92: 690–695

[215] Wu F , Yang Q , Mi Y , Wang F , Cai K , Zhang Y , Wang Y , Wang X , Gui Y , Li Q . miR-29b-3p inhibitor alleviates hypomethylation-related aberrations through a feedback loop between miR-29b-3p and DNA methylation in cardiomyocytes. Front Cell Dev Biol 2022; 10: 788799

[216] Yadav P , Subbarayalu P , Medina D , Nirzhor S , Timilsina S , Rajamanickam S , Eedunuri V , Gupta YK , Zheng S , Abdelfattah N , Huang Y , Vadlamudi R , Hromas R , Meltzer P , Houghton P , Chen Y , Rao MK . M⁶A RNA methylation regulates histone ubiquitination to support cancer growth and progression. Cancer Res 2022; 82(10): 1872–1889

[217] Kan RL , Chen J , Sallam T . Crosstalk between epitranscriptomic and epigenetic mechanisms in gene regulation. Trends Genet 2022; 38(2): 182–193

[218] Huang H , Weng H , Zhou K , Wu T , Zhao BS , Sun M , Chen Z , Deng X , Xiao G , Auer F , Klemm L , Wu H , Zuo Z , Qin X , Dong Y , Zhou Y , Qin H , Tao S , Du J , Liu J , Lu Z , Yin H , Mesquita A , Yuan CL , Hu YC , Sun W , Su R , Dong L , Shen C , Li C , Qing Y , Jiang X , Wu X , Sun M , Guan JL , Qu L , Wei M , Müschen M , Huang G , He C , Yang J , Chen J . Histone H3 trimethylation at lysine 36 guides m6A RNA modification co-transcriptionally. Nature 2019; 567(7748): 414–419

[219] Xu W , Li J , He C , Wen J , Ma H , Rong B , Diao J , Wang L , Wang J , Wu F , Tan L , Shi YG , Shi Y , Shen H . METTL3 regulates heterochromatin in mouse embryonic stem cells. Nature 2021; 591(7849): 317–321

[220] Wang Y , Wang C , Guan X , Ma Y , Zhang S , Li F , Yin Y , Sun Z , Chen X , Yin H . PRMT3‐mediated arginine methylation of METTL14 promotes malignant progression and treatment resistance in endometrial carcinoma. Adv Sci (Weinh) 2023; 10(36): 2303812

[221] Zhen J , Sheng X , Chen T , Yu H . Histone acetyltransferase Kat2a regulates ferroptosis via enhancing Tfrc and Hmox1 expression in diabetic cardiomyopathy. Cell Death Dis 2024; 15(6): 406

[222] Arcidiacono OA , Krejčí J , Bártová E . The distinct function and localization of METTL3/METTL14 and METTL16 enzymes in cardiomyocytes. Int J Mol Sci 2020; 21(21): 8139

[223] Baylin PA . A decade of exploring the cancer epigenome-biological and translational implications. Nat Rev Cancer 2011; 11(10): 726–734

[224] Jiang Y , Liu L , Xiang Q , He X , Wang Y , Zhou D , Zou C , Chen Q , Peng M , He J , Jiang X , Xiang T , Yang Y . SEPT9_v2, frequently silenced by promoter hypermethylation, exerts anti-tumor functions through inactivation of Wnt/β-catenin signaling pathway via miR92b-3p/FZD10 in nasopharyngeal carcinoma cells. Clin Epigenetics 2020; 12(1): 41

[225] Xu RH , Wei W , Krawczyk M , Wang W , Luo H , Flagg K , Yi S , Shi W , Quan Q , Li K , Zheng L , Zhang H , Caughey BA , Zhao Q , Hou J , Zhang R , Xu Y , Cai H , Li G , Hou R , Zhong Z , Lin D , Fu X , Zhu J , Duan Y , Yu M , Ying B , Zhang W , Wang J , Zhang E , Zhang C , Li O , Guo R , Carter H , Zhu JK , Hao X , Zhang K . Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma. Nat Mater 2017; 16(11): 1155–1161

[226] Panagal MS R SKP SM BM KGopinathe VSivakumare PSekar D MicroRNA21 and the various types of myeloid leukemia. Cancer Gene Ther 2018; doi:10.1038/s41417-018-0025-2

[227] Sekar D , Saravanan S , Karikalan K , Thirugnanasambantham K , Lalitha P , Islam VI . Role of microRNA 21 in mesenchymal stem cell (MSC) differentiation: a powerful biomarker in MSCs derived cells. Curr Pharm Biotechnol 2015; 16(1): 43–48

[228] Zhang C , Yu W , Wang L , Zhao M , Guo Q , Lv S , Hu X , Lou J . Analysis of the SHOX2 and RASSF1A panel in bronchoalveolar lavage fluid for lung cancer diagnosis. J Cancer 2017; 8(17): 3585–3591

[229] Liang W , Chen Z , Li C , Liu J , Tao J , Liu X , Zhao D , Yin W , Chen H , Cheng C , Yu F , Zhang C , Liu L , Tian H , Cai K , Liu X , Wang Z , Xu N , Dong Q , Chen L , Yang Y , Zhi X , Li H , Tu X , Cai X , Jiang Z , Ji H , Mo L , Wang J , Fan JB , He J . Accurate diagnosis of pulmonary nodules using a non-invasive DNA methylation test. J Clin Invest 2021; 131(10): e145973

[230] Tuaeva NO , Falzone L , Porozov YB , Nosyrev AE , Trukhan VM , Kovatsi L , Spandidos DA , Drakoulis N , Kalogeraki A , Mamoulakis C , Tzanakakis G , Libra M , Tsatsakis A . Translational application of circulating DNA in oncology: review of the last decades achievements. Cells 2019; 8(10): 1251

[231] Barault L , Amatu A , Bleeker FE , Moutinho C , Falcomatà C , Fiano V , Cassingena A , Siravegna G , Milione M , Cassoni P , De Braud F , Rudà R , Soffietti R , Venesio T , Bardelli A , Wesseling P , de Witt Hamer P , Pietrantonio F , Siena S , Esteller M , Sartore-Bianchi A , Di Nicolantonio F . Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer. Ann Oncol 2015; 26(9): 1994–1999

[232] Luo H , Zhao Q , Wei W , Zheng L , Yi S , Li G , Wang W , Sheng H , Pu H , Mo H , Zuo Z , Liu Z , Li C , Xie C , Zeng Z , Li W , Hao X , Liu Y , Cao S , Liu W , Gibson S , Zhang K , Xu G , Xu R . Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer. Sci Transl Med 2020; 12(524): eaax7533

[233] Fiorito G , Guarrera S , Valle C , Ricceri F , Russo A , Grioni S , Mattiello A , Di Gaetano C , Rosa F , Modica F , Iacoviello L , Frasca G , Tumino R , Krogh V , Panico S , Vineis P , Sacerdote C , Matullo G . B-vitamins intake, DNA-methylation of one carbon metabolism and homocysteine pathway genes and myocardial infarction risk: the EPICOR study. Nutr Metab Cardiovasc Dis 2014; 24(5): 483–488

[234] Ek WE , Hedman ÅK , Enroth S , Morris AP , Lindgren CM , Mahajan A , Gustafsson S , Gyllensten U , Lind L , Johansson Å . Genome-wide DNA methylation study identifies genes associated with the cardiovascular biomarker GDF-15. Hum Mol Genet 2015; 25(4): 817–827

[235] Nakatochi M , Ichihara S , Yamamoto K , Naruse K , Yokota S , Asano H , Matsubara T , Yokota M . Epigenome-wide association of myocardial infarction with DNA methylation sites at loci related to cardiovascular disease. Clin Epigenetics 2017; 9(1): 54

[236] Navas-Acien A , Domingo-Relloso A , Subedi P , Riffo-Campos AL , Xia R , Gomez L , Haack K , Goldsmith J , Howard BV , Best LG , Devereux R , Tauqeer A , Zhang Y , Fretts AM , Pichler G , Levy D , Vasan RS , Baccarelli AA , Herreros-Martinez M , Tang WY , Bressler J , Fornage M , Umans JG , Tellez-Plaza M , Fallin MD , Zhao J , Cole SA . Blood DNA methylation and incident coronary heart disease: evidence from the strong heart study. JAMA Cardiol 2021; 6(11): 1237–1246

[237] Zheng Y , Joyce BT , Hwang SJ , Ma J , Liu L , Allen NB , Krefman AE , Wang J , Gao T , Nannini DR , Zhang H , Jacobs DR Jr , Gross MD , Fornage M , Lewis CE , Schreiner PJ , Sidney S , Chen D , Greenland P , Levy D , Hou L , Lloyd-Jones DM . Association of cardiovascular health through young adulthood with genome-wide DNA methylation patterns in midlife: the CARDIA study. Circulation 2022; 146(2): 94–109

[238] Tremblay F , Xiong Q , Shah SS , Ko CW , Kelly K , Morrison MS , Giancarlo C , Ramirez RN , Hildebrand EM , Voytek SB , El Sebae GK , Wright SH , Lofgren L , Clarkson S , Waters C , Linder SJ , Liu S , Eom T , Parikh S , Weber Y , Martinez S , Malyala P , Abubucker S , Friedland AE , Maeder ML , Lombardo A , Myer VE , Jaffe AB . A potent epigenetic editor targeting human PCSK9 for durable reduction of low-density lipoprotein cholesterol levels. Nat Med 2025; 31(4): 1329–1338

[239] Cappelluti MA , Poeta VM , Valsoni S , Quarato P , Merlin S , Merelli I , Lombardo A . Durable and efficient gene silencing in vivo by hit-and-run epigenome editing. Nature 2024; 627(8003): 416–423

[240] Horie T , Ono K . VERVE-101: a promising CRISPR-based gene editing therapy that reduces LDL-C and PCSK9 levels in HeFH patients. Eur Heart J Cardiovasc Pharmacother 2024; 10(2): 89–90

[241] Hooper AJ , Tang XL , Burnett JR . VERVE-101, a CRISPR base-editing therapy designed to permanently inactivate hepatic PCSK9 and reduce LDL-cholesterol. Expert Opin Investig Drugs 2024; 33(8): 753–756

RIGHTS & PERMISSIONS

Higher Education Press